Literature DB >> 33915000

Predictors of longer hospitalization of maxillofacial infections-a 17-year retrospective study.

Ruta Rasteniene1, Milda Vitosyte1, Dainora Jankauskaite1, Jolanta Aleksejuniene2.   

Abstract

OBJECTIVES: To evaluate treatment outcomes in patients with severe maxillofacial infections requiring hospital care during a 17-year period.
METHODS: A retrospective cohort study reviewed 5,465 medical records, and the following data were collected: the reason for infection, locations of inflamed regions, treatment provided, bacteriological findings, and treatment outcomes. Other information included sociodemographic characteristics (age, gender), presence of systemic diseases, and smoking history.
RESULTS: The annual incidence rate of patients with acute maxillofacial infections was 206 ± 19 cases with a male to female ratio 1.4:1.0, a mean hospital stay of 7.9 ± 4.9 days. Older age (>65 years), smoking and systemic diseases (diabetes), the causative tooth (molar), and need for extraoral incision predicted longer hospitalization. Intravenous penicillin was the most common drug prescribed in 50.5% of cases. A total of 132 different microorganisms were identified. The highest microorganism resistance occurred for metronidazole and the highest sensitivity was to clindamycin.
CONCLUSIONS: Increased age, smoking, diabetes, causative tooth, and the occurrence of several infected spaces were associated with a longer hospital stay. Streptococcus α haemolyticus was the most common microorganism found in more than 70.0% of cases that were sensitive to intravenous penicillin.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  hospital stay; microorganism resistance; odontogenic maxillofacial infections

Mesh:

Substances:

Year:  2021        PMID: 33915000     DOI: 10.1111/odi.13894

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   4.068


  2 in total

1.  MRI of odontogenic maxillofacial infections: diagnostic accuracy and reliability.

Authors:  Jaakko Heikkinen; Viljami Jokihaka; Janne Nurminen; Ville Jussila; Jarno Velhonoja; Heikki Irjala; Tero Soukka; Tatu Happonen; Jorma Järnstedt; Mikko Nyman; Kimmo Mattila; Jussi Hirvonen
Journal:  Oral Radiol       Date:  2022-08-09       Impact factor: 1.882

2.  A Five-Year Retrospective Study of 746 Cases with Maxillofacial Space Infection in Western China.

Authors:  Peihan Wang; Yanling Huang; Jie Long
Journal:  Infect Drug Resist       Date:  2022-08-31       Impact factor: 4.177

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.